X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CELLULAR IMMUNOLOGY

期刊標題檢索 CELL IMMUNOL 最新評論: Yesterday I submitted an article, but it was rejected after 2 hours, ... (2023-06-14)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CELLULAR IMMUNOLOGY]您好,您是該頁面的第 45457 位訪客。

期刊簡介
期刊名稱CELLULAR IMMUNOLOGY CELLULAR IMMUNOLOGY
LetPub Score
6.4
52 ratings
Rate

Reputation
7.6

Influence
5.3

Speed
7.1

期刊簡稱CELL IMMUNOL
ISSN0008-8749
E-ISSN1090-2163
h-index83
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.201.0110.725
Subject fieldQuartilesRankPercentile
Category: Immunology and Microbiology
Subcategory: Immunology
Q278 / 236

自引率 (2023-2024)2.70%自引率趨勢
掲載範囲
Cellular Immunology publishes original investigations concerned with the immunological activities of cells in experimental or clinical situations. The scope of the journal encompasses the broad area of in vitro and in vivo studies of cellular immune responses. Purely clinical descriptive studies are not considered.

Research Areas include:

• Antigen receptor sites
• Autoimmunity
• Delayed-type hypersensitivity or cellular immunity
• Immunologic deficiency states and their reconstitution
• Immunologic surveillance and tumor immunity
• Immunomodulation
• Immunotherapy
• Lymphokines and cytokines
• Nonantibody immunity
• Parasite immunology
• Resistance to intracellular microbial and viral infection
• Thymus and lymphocyte immunobiology
• Transplantation immunology
• Tumor immunity.
官方網站http://www.journals.elsevier.com/cellular-immunology/
在線稿件提交https://www.editorialmanager.com/CIMM
開放訪問No
出版商Academic Press Inc.
主題領域生物
出版國/地區UNITED STATES
發行頻率月刊
創刊年1970
每年文章數61每年文章數趨勢
黃金OA百分比25.37%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ299/205
IMMUNOLOGYSCIEQ282/181
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-8749%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
來自Elsevier的數據: Average 5.8 Week(s)
競爭力 *來自作者的數據: About 75%
在線文章發布時間來自Elsevier的數據: Average 11.7 Week(s)
參考鏈接
相關期刊 【CELLULAR IMMUNOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 40.00
    Annual Review of ImmunologyH-index: 279

    CiteScore: 57.20
    ImmunityH-index: 355

    CiteScore: 49.40
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 31.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 25.10
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 26.60
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 24.70
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 29.60
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 27.90
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology316309
    JOURNAL OF IMMUNOLOGY156694
    Immunity107936
    Cellular & Molecular Immunology107434
    Vaccine104773
    JOURNAL OF EXPERIMENTAL MEDICINE99453
    MICROBIAL PATHOGENESIS94242
    MOLECULAR IMMUNOLOGY91044
    INFLAMMATION89742
    BRAIN BEHAVIOR AND IMMUNITY84729
  •  

    CELLULAR IMMUNOLOGY CELLULAR IMMUNOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [CELLULAR IMMUNOLOGY] 的評論撰寫評論
作者: Arlen Lyly


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-14 16:54:14 評論於
Yesterday I submitted an article, but it was rejected after 2 hours, stating that the clinical data was not suitable for publication
(0) 讚! | Arlen Lyly

作者: 卧龙正毅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-15 22:22:04 評論於
Who should I send the reminder to? It has been over two months and my paper is still under review. The system shows that only one reviewer has reviewed it. Can I send a reminder?
(0) 讚! | 卧龙正毅

作者: 卧龙正毅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-15 21:17:37 評論於
It has been over two months since the manuscript submission and only one reviewer has accepted and completed the review. It seems like finding reviewers is quite challenging
(0) 讚! | 卧龙正毅

作者: 元修小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-24 12:53:50 評論於
How is your article coming along?
(0) 讚! | 元修小可爱

作者: 卧龙正毅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-06 23:01:59 評論於
**
The official website says the First decision is 14 days, but it's been longer and still shows as "with editor." Should we follow up? I'm in a rush to graduate, so if it's going to be rejected, please do it quickly.

**
(0) 讚! | 卧龙正毅

作者: 多罗海凡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-22 12:50:43 評論於
Do you want the original data? I have a set of original data that my company did not provide me because of money issues
(0) 讚! | 多罗海凡

作者: Brook Hutt


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-04 15:43:34 評論於
May I ask how long it takes for you to receive an online message?
(0) 讚! | Brook Hutt

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:26:55 評論於
Please translate the following passage into English and Japanese, and title them ":" and ":" respectively
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:51:06 評論於
Could you please provide me with more information about this product?
(0) 讚! | 维尔娜菲茨杰拉德

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 19:40:44 評論於
What is the minimum number of keywords?
(0) 讚! | 上清雨真

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 18:41:49 評論於
What is the maximum number of keywords that can be included?
(0) 讚! | 破戒阳平

作者: 无极海旺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-07 12:17:04 評論於
The paper was received online, and it took half a month to change its status to under review after revision. It was finally accepted at the end of June, three weeks later
(0) 讚! | 无极海旺

作者: 努力啊大白山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-30 23:51:45 評論於
The latest IF=4.868
(0) 讚! | 努力啊大白山

作者: 努力啊大白山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-24 15:53:28 評論於
2021-4-1 Submitted to Journal
2021-4-1 With Editor
2021-4-14 Under Review
2021-5-3 Under Review
2021-5-18 Major Revise
2021-6-5 re-Submitted to Journal
2021-6-5 With Editor
2021-6-5 Under Review
2021-6-21 Required Reviews Completed
2021-6-24 Accept
The entire submission process took nearly three months, with the main reviewer being too slow and the editorial efficiency being acceptable. There were two reviewers, both providing a lot of revision comments and requesting additional experiments, which were all rejected. After replying to the comments, there were over ten pages of PDF. Overall, the submission difficulty was moderate
(0) 讚! | 努力啊大白山

作者: 能帮我发SCI嘛


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2021-06-24 09:24:27 評論於
2021-4-1 Submitted to Journal
2021-4-1 With Editor
2021-4-14 Under Review
2021-5-3 Under Review
2021-5-18 Major Revise
2021-6-5 re-Submitted to Journal
2021-6-5 With Editor
2021-6-5 Under Review
2021-6-21 Required Reviews Completed
2021-6-24 Accept

The entire submission process took nearly 3 months, with the main reviewers being slow in their speed, while the efficiency of the editorial department was decent. There were two reviewers who provided numerous modification suggestions and requested additional experiments, but all requests for additional experiments were rejected. After responding to the comments, there were over ten pages of PDF. Overall, the difficulty of the submission was moderate.
(3) 讚! | 能帮我发SCI嘛

作者: 华清雁香


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-21 22:26:31 評論於
How is your article coming along?
(0) 讚! | 华清雁香

作者: 无极海旺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-19 14:49:07 評論於
I sent a reminder email, and the journal manager replied saying it has been rejected by 14 reviewers, but is still under consideration for invitation. The manager also helped me by submitting my reminder email to the editor
(0) 讚! | 无极海旺

作者: 龙鳞兰梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-17 11:23:51 評論於
How can I see the rejected manuscript?
(0) 讚! | 龙鳞兰梦

作者: 努力啊大白山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-13 12:50:22 評論於
My application is still under review
(0) 讚! | 努力啊大白山

作者: 无极海旺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-13 12:21:56 評論於
The editor requested revised submissions of the manuscript, one with track changes for review and one without for publication. They mentioned that there may be a need for a re-review, but they do not anticipate sending it to any additional reviewers. How do you feel about this?
(0) 讚! | 无极海旺

作者: 努力啊大白山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-12 18:37:05 評論於
Can you please translate the following paragraph into English and Japanese and submit the revised version? Will it be sent back for review again?
(0) 讚! | 努力啊大白山

作者: 无极海旺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-12 08:01:43 評論於
Today the editor replied, so I made revisions and resubmitted. Only one reviewer provided feedback, while 14 reviewers rejected the submission
(0) 讚! | 无极海旺

作者: 无极海旺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-10 22:56:02 評論於
Has your status changed yet? My under review date has changed 3 times already, around the same time as yours. The last date change was on May 1st
(0) 讚! | 无极海旺

作者: 努力啊大白山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-04 19:39:16 評論於
April 14th, under review
May 3rd, under review
Dates changed, but status unchanged
(0) 讚! | 努力啊大白山

作者: 无极海旺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-02 20:59:28 評論於
Research focus: Immunology
Experience sharing: Submitted on April 6th, date changed three times after being under review, on April 16th, April 28th, May 1st, still under review now. Originally aiming to submit for the first decision with a 2.4-week turnaround time as mentioned on the homepage, but still no news. Sent a reminder email yesterday, but the editor has not replied, feeling helpless and can only pray for a miracle!
(0) 讚! | 无极海旺

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [CELLULAR IMMUNOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*